在孕妇患者中断布普伦诺芬
Neil Patel1, John O'Brien1, Cynthia Cockerham1
1Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Kentucky, Lexington, KY, USA.
概括
这项研究发现,怀孕期间断奶布诺啡因导致新生儿阿片类药物戒断综合征 (NOWS) 发生率显著降低,出生体重百分比改善. 孕产妇和新生儿的结局没有受到布普伦诺芬断奶的负面影响.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿医学 新生儿医学
- 成 药物 药物 药物 药物
背景情况:
- 怀孕期间的阿片类药物使用障碍 (OUD) 对母亲和新生儿的健康构成重大挑战.
- 治疗阿片类药物使用障碍 (MOUD) 的药物,特别是布普伦诺芬,是标准的护理,但最佳的管理策略,包括断奶,需要进一步调查.
- 了解布普伦诺芬断奶对怀孕结果的影响对于基于证据的临床实践至关重要.
研究的目的:
- 为了比较孕妇和新生儿的结局与OUD的孕妇和新生儿的结局,这些孕妇和新生儿在整个怀孕期间一直服用布普伦诺芬.
- 在临床环境中评估渐进式布普伦诺芬断奶的安全性和有效性.
主要方法:
- 一项前性队列研究包括在2015-2022年期间接受布普伦诺芬治疗的OUD孕妇患者.
- 患者被分为两组:一个实验组接受了布普伦诺芬断奶,一个控制组维持在布普伦诺芬.
- 包括新生儿阿片类药物戒断综合征 (NOWS),出生体重和母亲并发症在内的结果使用费舍尔的精确测试进行了比较.
主要成果:
- 与对照组 (n=295) 相比,布普伦诺芬断奶组 (n=39) 的NOWS治疗率显著降低 (23%对47%,p=0.006) 和较低的最高芬尼根得分.
- 断奶组的出生体重百分位数显著更高 (44.3比34.8,p=0.03).
- 两组之间在分娩时的妊娠年龄,分娩方式或产妇并发症方面没有发现显著差异.
结论:
- 怀孕期间的布普伦诺芬断奶可能与新生儿阿片类药物戒断综合征 (NOWS) 的减少和出生体重的改善有关,而不会增加母亲或新生儿的发病率.
- 这些发现表明,精心管理的布普伦诺芬断奶可能是选择OUD的孕妇患者的可行选择.
- 需要对更大的样本进行进一步的研究,以验证这些发现并完善断奶协议.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
277
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
277
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drugs for Treatment of Constipation-Predominant IBS
161
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
161
Drug Abuse and Addiction: Pharmacological Phenomena
469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134


